Patents by Inventor Christopher E. Andoniou

Christopher E. Andoniou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treatment
    Patent number: 11986495
    Abstract: This invention relates generally to the inhibition of cytomegalovirus (CMV) reactivation in immunosuppressed subjects, including subjects receiving hematopoietic or solid organ transplants. The present invention is particularly relevant for the treatment of CMV reactivation or infection in subjects with graft-versus-hosts disease (GVHD) or under immunosuppressive therapy.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: May 21, 2024
    Assignees: Lions Eye Institute Limited, QIMR Berghofer Medical Research Institute
    Inventors: Mariapia A. Degli-Esposti, Geoffrey R. Hill, Christopher E. Andoniou, Peter Fleming
  • METHOD OF TREATMENT
    Publication number: 20200289559
    Abstract: This invention relates generally to the inhibition of cytomegalovirus (CMV) reactivation in immunosuppressed subjects, including subjects receiving hematopoietic or solid organ transplants. The present invention is particularly relevant for the treatment of CMV reactivation or infection in subjects with graft-versus-hosts disease (GVHD) or under immunosuppressive therapy.
    Type: Application
    Filed: November 28, 2018
    Publication date: September 17, 2020
    Inventors: Maria A. Degli-Esposti, Geoffrey R. Hill, Christopher E. Andoniou, Peter Fleming